Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 21.125.79-22.6416.5114.91

What is the latest Core EBITDA Growth ratio of GLENMARK PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of GLENMARK PHARMACEUTICALS is 21.12 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202521.12
Mar20245.79
Mar2023-22.64
Mar202216.51
Mar202114.91

How is Core EBITDA Growth of GLENMARK PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2025 21.12
264.77
Mar2024 5.79
Positive
Mar2023 -22.64
Negative
Mar2022 16.51
10.73
Mar2021 14.91 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹66,352.3 Cr -1.1% 2.3% 62.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹441,610.0 Cr -2.1% 13.6% 6.3% Stock Analytics
DIVIS LABORATORIES ₹179,279.0 Cr -2% 6.2% 3.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹150,649.0 Cr 0.5% 8.2% 39% Stock Analytics
CIPLA ₹114,469.0 Cr 1.3% 9.5% -4.6% Stock Analytics
DR REDDYS LABORATORIES ₹110,955.0 Cr 0.6% 1% 8.8% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-1.1%

2.3%

62.2%

SENSEX

1.1%

-2.1%

-6.4%


You may also like the below Video Courses